title: Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations.
abstract: Tuberous sclerosis (TSC) is an autosomal dominant disorder caused by mutations in either of two genes, TSC1 and TSC2. Point mutations and small indels account for most TSC1 and TSC2 mutations. We examined 261 TSC DNA samples (209 small-mutation-negative and 52 unscreened) for large deletion/duplication mutations using multiplex ligation-dependent probe amplification (MLPA) probe sets designed to permit interrogation of all TSC1/2 exons, as well as 15-50 kb of flanking sequence. Large deletion/duplication mutations in TSC1 and TSC2 were identified in 54 patients, of which 50 were in TSC2, and 4 were in TSC1. All but two mutations were deletions. Only 13 deletions were intragenic in TSC2, and one in TSC1, so that 39 (73%) deletions extended beyond the 5', 3' or both ends of TSC1 or TSC2. Mutations were identified in 24% of small-mutation-negative and 8% of unscreened samples. Eight of 54 (15%) mutations were mosaic, affecting 34-62% of cells. All intragenic mutations were confirmed by LR-PCR. Genotype/phenotype analysis showed that all (21 of 21) patients with TSC2 deletions extending 3' into the PKD1 gene had kidney cysts. Breakpoints of intragenic deletions were randomly distributed along the TSC2 sequence, and did not preferentially involve repeat sequence elements. Our own 20-plex probe sets gave more robust performance than the 40-plex probe sets from MRC-Holland. We conclude that large deletions in TSC1 and TSC2 account for about 0.5 and 6% of mutations seen in TSC patients, respectively, and MLPA is a highly sensitive and accurate detection method, including for mosaicism.
authors.affiliation: Genetics Laboratory, Division of Translational Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
authors.forename: Piotr
authors.initials: P
authors.lastname: Kozlowski
authors.forename: Penelope
authors.initials: P
authors.lastname: Roberts
authors.forename: Sandra
authors.initials: S
authors.lastname: Dabora
authors.forename: David
authors.initials: D
authors.lastname: Franz
authors.forename: John
authors.initials: J
authors.lastname: Bissler
authors.forename: Hope
authors.initials: H
authors.lastname: Northrup
authors.forename: Kit Sing
authors.initials: KS
authors.lastname: Au
authors.forename: Ross
authors.initials: R
authors.lastname: Lazarus
authors.forename: Dorota
authors.initials: D
authors.lastname: Domanska-Pakiela
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Kotulska
authors.forename: Sergiusz
authors.initials: S
authors.lastname: Jozwiak
authors.forename: David J
authors.initials: DJ
authors.lastname: Kwiatkowski
mesh_terms: D019457:Chromosome Breakage; D020440:Gene Duplication; D005821:Genetic Techniques; D005838:Genotype; D006801:Humans; D009030:Mosaicism; D010641:Phenotype; D017384:Sequence Deletion; D014402:Tuberous Sclerosis / Q000235:genetics; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: C000624650:TSC1 protein, human; C000624653:TSC2 protein, human; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins